Could bone marrow cells prolong life? Recruitment of 3,000 patients will begin across the EU later this year for the BAMI (Bone Marrow Cells in Acute Myocardial Infarction) study, which will test whether stem cells taken from bone marrow and administered after a heart attack will prolong life. Mark Nicholls reports
Michael Rühl from the University of Greifswald, Working Group on Immunoadsorption and Cardiovascular Technology, describes therapies to tackle familial hypercholesterolemia
For the first time, a EU agency recommends a gene therapy drug for commercial release in Europe. The European Medicine's Agency announced in late July 2012 that its Committee for Medicinal Products for Human Use (CHMP) recommends Glybera for commercial release in the European Union
Siemens Healthcare Diagnostics launched Aptio™ Automation¹, the company’s next generation laboratory automation platform, at the 2012 AACC and ASCLS Annual Meetings and Clinical Lab Expo in Los Angeles, July 15 – 19 (Booth #1701). Aptio Automation promises to transform laboratory operations by combining Siemens’ industry-leading workflow expertise with peak performance, adaptability and…
Alere introduced its new PBP2a test, a rapid, lateralflow assay that detects the PBP2a protein found in MRSA directly from Staphylococcus aureus isolates. It is a costeffective, targeted approach to identifying MRSA, the firm points out. Providing results in five minutes, the assay uses samples from cultures (wound, skin, urine, etc.) and has builtin quality controls on every test strip.
Prevention is better than a fight against an infected wound – but, to avoid a battle you must know your enemy – and the wound’s infection risk level. Unfortunately, there are no generally accepted definitions for those risk levels. Now, the introduction of a new clinical assessment score – named W.A.R. (wound at risk) – which makes standardised classification of ‘risky’ wounds…
By integrating all necessary pre-analytical and analytical steps into one solution, the recently CE-marked Unyvero system, which is now commercially available in Europe, provides pathogen identification and antibiotic resistance marker information without needing expert staff and a sophisticated infrastructure, its manufacturer Curetis reports. Of even greater interest is its range of targets.
Along with a call for earlier identification and intervention in sepsis cases, intensive care consultant Dr Ron Daniels also stressed that timely intervention is cost-effective for health systems as it leads to fewer sepsis patients needing treatment in intensive care units (ICU).
Scientists in Scotland have developed a new test using a strip with electrical sensors that can show whether wounds or lesions have been infected with bacteria, including MRSA, Mark Nicholls reports. The hand-held test provides rapid results and allows almost immediate detection of bacteria, which means patients can be given more effective drugs much quicker and speed up their recovery.
With complementary portfolios, GlaxoSmithKline (GSK) and B. Braun have been working together since mid- May to develop a complete one-stop system for the decontamination of MRSA patients
Switzerland - It is a classic problem in any business. Everyone is working so hard to keep up with the rapid pace of orders that no one has time to get ahead. For the clinical laboratory the problem has grown greater each year, to the point that today’s new high-throughput instruments are still shackled to slow-throughput wires.
Devised by the European Liver Test group, the new, non-invasive Enhanced Liver Fibrosis (ELF) test on Siemens ADVIA Centaur Immunoassay Systems can identify, in under an hour, bloodbased biomarkers to detect the amount of fibrosis in the liver.
Molecular diagnostics is one of the most important technological advances in clinical diagnostics, seeing the €3.6 billion market grow 10% in constant currency (CC) in 2010 and predicted continual growth well above the diagnostic industry rates. The recipe for success in this field lies in three critical components: core technology, automation and menu. During our interview with Marc Meyer, the…
Abbott Laboratories has obtained European Union approval to market its rapid, Plex-ID instrument, along with three assays for use on the system.
The Global Sepsis Alliance (GSA) is urging healthcare providers, patients and policymakers worldwide to treat sepsis as a medical emergency. “Tens of millions of people die from sepsis each year, making it the likely leading cause of death worldwide. Sepsis kills regardless of age, ethnicity, location and access to care,” said Konrad Reinhart, M.D., Chairman of the GSA and director of the…
Early arthritis is characterized by autoreactivity (reactivity against self-antigens) of T-B lymphocytes and by the synthesis of autoantibodies crucial for diagnosis (biomarkers). Detection of panels of autoantibodies increases the sensitivity and specificity for the diagnosis of arthritis. The variability in the performance of autoantibody assays may impact the predictive value. Confirmation of…
With his clinical and experimental research on the acute care of critically ill patients through round-the-clock monitoring of the vital functions Max Harry Weil revolutionised intensive care medicine and became known as its founding father. He died in 2011 in California, aged 84. Thus the first Max Harry Weil Lecture will be held in his honour at this ISICEM.
When the ISICEM 2012 opens this March, Brussels will again experience a healthy influx of medical specialists intent on hearing the most recent, clinically relevant developments in research, therapy and management of the critically ill.
The 500-bed Warrington Hospital in the north-west of England has introduced rapid, accurate POCT to its wards. The hospital was one of the first in the UK to install Siemens RAPIDLab 1200 Blood Gas Analyzers and the RAPIDComm v3.0 Data Management System. More recently, it has installed Clinitek Status Connect systems to further enhance its operations.
Artel is launching the new MVS Multichannel Verification System, an objective performance assessment and optimization tool for automated liquid handlers. The MVS offers accuracy and precision information for any liquid handling device with up to 384-channels, allowing for confidence in assay data.
With handyscope, FotoFinder presents the first device for mobile skin cancer examination via the iPhone. This digital handheld dermatoscope allows doctors to capture and save microscopic pictures of moles using the iPhone, the handyscope device and the corresponding handyscope app.
Imperial College Healthcare NHS Trust has one of the largest immunohistochemistry / in situ hybridization (IHC / ISH) workloads in the United Kingdom, performing almost 120,000 IHC slides a year.
‘We are all aware of the importance of early diagnosis and rapid appropriate treatment of patients with severe sepsis. Yet, many patients still do not receive satisfactory early management and the application of recent guidelines for sepsis management is still inadequate,’ writes Jean-Louis Vincent MD PhD, from the Intensive Care Department, Erasme Hospital, Université Libre de Bruxelles,…
Debuting at the AACC meeting was the first free mobile application to help consumers decipher their own medical tests. Created for use on an iPhone, iPad and Android smartphone, the Lab Tests Online app connects to a site promising to provide reliable, unbiased information that enables them to have more informed conversations with their doctors.
The health of the laboratory/ clinician relationship has always served as a good indicator of the overall quality of a given healthcare network. Historically, labs focused ‘heads down’ on delivering excellent test results, but today appear to be expanding their horizons to partner with clinicians for better patient care.